130 related articles for article (PubMed ID: 20709091)
1. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment.
Taguchi K; Miyasato M; Ujihira H; Watanabe H; Kadowaki D; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
Toxicol Appl Pharmacol; 2010 Nov; 248(3):234-41. PubMed ID: 20709091
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.
Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M
Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model.
Sakai H; Horinouchi H; Masada Y; Takeoka S; Ikeda E; Takaori M; Kobayashi K; Tsuchida E
Biomaterials; 2004 Aug; 25(18):4317-25. PubMed ID: 15046922
[TBL] [Abstract][Full Text] [Related]
4. Physiological capacity of the reticuloendothelial system for the degradation of hemoglobin vesicles (artificial oxygen carriers) after massive intravenous doses by daily repeated infusions for 14 days.
Sakai H; Masada Y; Horinouchi H; Ikeda E; Sou K; Takeoka S; Suematsu M; Takaori M; Kobayashi K; Tsuchida E
J Pharmacol Exp Ther; 2004 Dec; 311(3):874-84. PubMed ID: 15297471
[TBL] [Abstract][Full Text] [Related]
5. Repeated injection of high doses of hemoglobin-encapsulated liposomes (hemoglobin vesicles) induces accelerated blood clearance in a hemorrhagic shock rat model.
Taguchi K; Iwao Y; Watanabe H; Kadowaki D; Sakai H; Kobayashi K; Horinouchi H; Maruyama T; Otagiri M
Drug Metab Dispos; 2011 Mar; 39(3):484-9. PubMed ID: 21123166
[TBL] [Abstract][Full Text] [Related]
6. Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.
Taguchi K; Urata Y; Anraku M; Watanabe H; Kadowaki D; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Maruyama T; Otagiri M
Drug Metab Dispos; 2009 Nov; 37(11):2197-203. PubMed ID: 19679674
[TBL] [Abstract][Full Text] [Related]
7. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system.
Sakai H; Horinouchi H; Tomiyama K; Ikeda E; Takeoka S; Kobayashi K; Tsuchida E
Am J Pathol; 2001 Sep; 159(3):1079-88. PubMed ID: 11549600
[TBL] [Abstract][Full Text] [Related]
9. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers).
Sakai H; Tsuchida E; Horinouchi H; Kobayashi K
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):81-91. PubMed ID: 17364473
[TBL] [Abstract][Full Text] [Related]
10. Biological Responsiveness and Metabolic Performance of Liposome-Encapsulated Hemoglobin (Hemoglobin-Vesicles) in Apolipoprotein E-Deficient Mice after Massive Intravenous Injection.
Taguchi K; Nagao S; Yamasaki K; Sakai H; Seo H; Maruyama T; Otagiri M
Biol Pharm Bull; 2015; 38(10):1606-16. PubMed ID: 26424021
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin vesicles and red blood cells as carriers of carbon monoxide prior to oxygen for resuscitation after hemorrhagic shock in a rat model.
Sakai H; Horinouchi H; Tsuchida E; Kobayashi K
Shock; 2009 May; 31(5):507-14. PubMed ID: 18827742
[TBL] [Abstract][Full Text] [Related]
12. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
[TBL] [Abstract][Full Text] [Related]
13. Acute 40 percent exchange-transfusion with hemoglobin-vesicles (HbV) suspended in recombinant human serum albumin solution: degradation of HbV and erythropoiesis in a rat spleen for 2 weeks.
Sakai H; Horinouchi H; Yamamoto M; Ikeda E; Takeoka S; Takaori M; Tsuchida E; Kobayashi K
Transfusion; 2006 Mar; 46(3):339-47. PubMed ID: 16533274
[TBL] [Abstract][Full Text] [Related]
14. Effects of hemoglobin vesicles, a liposomal artificial oxygen carrier, on hematological responses, complement and anaphylactic reactions in rats.
Abe H; Azuma H; Yamaguchi M; Fujihara M; Ikeda H; Sakai H; Takeoka S; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):157-72. PubMed ID: 17453702
[TBL] [Abstract][Full Text] [Related]
15. Alteration in the pharmacokinetics of hemoglobin-vesicles in a rat model of chronic liver cirrhosis is associated with Kupffer cell phagocyte activity.
Taguchi K; Miyasato M; Watanabe H; Sakai H; Tsuchida E; Horinouchi H; Kobayashi K; Maruyama T; Otagiri M
J Pharm Sci; 2011 Feb; 100(2):775-83. PubMed ID: 20799362
[TBL] [Abstract][Full Text] [Related]
16. Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions.
Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
J Intern Med; 2008 Jan; 263(1):4-15. PubMed ID: 18042220
[TBL] [Abstract][Full Text] [Related]
17. Use of hemoglobin vesicles during cardiopulmonary bypass priming prevents neurocognitive decline in rats.
Yamazaki M; Aeba R; Yozu R; Kobayashi K
Circulation; 2006 Jul; 114(1 Suppl):I220-5. PubMed ID: 16820576
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of single and repeated injection of hemoglobin-vesicles in hemorrhagic shock rat model.
Taguchi K; Maruyama T; Iwao Y; Sakai H; Kobayashi K; Horinouchi H; Tsuchida E; Kai T; Otagiri M
J Control Release; 2009 Jun; 136(3):232-9. PubMed ID: 19245823
[TBL] [Abstract][Full Text] [Related]
19. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
Sakai H; Tsuchida E
Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
